Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet

J Cell Physiol. 2010 Aug;224(2):501-8. doi: 10.1002/jcp.22151.

Abstract

Type 1 diabetes is inhibited in diabetes-prone BioBreeding (BBdp) rats fed a low-antigen hydrolyzed casein (HC) diet. In cereal-fed BBdp rats, islet expansion is defective accompanied by a futile upregulation of islet neogenesis without increased islet mass, due to a subtle blockage in islet cell cycle. We hypothesized that islet growth is enhanced before insulitis in HC-fed young BBdp rats and that islet neogenesis could be stimulated by a trophic factor, islet neogenesis-associated protein (INGAP). beta-Cell homeostasis was analyzed using immunohistochemistry, morphometry, laser capture microdissection and RT-PCR in BBdp rats fed HC or cereal diets. beta-cell proliferation in small and medium islets, and the number and area fraction of medium and large islets were increased in HC-fed animals. In situ islet cell cycle analysis revealed an increased proportion of proliferating S + G2 cells in medium and large islets of 25-45 day HC-fed rats. Expression of the cell cycle inhibitor, p16(INK4a) correlated with islet size and the percentage of p16(INK4a+) beta-cells increased in HC-fed BBdp rats, likely reflecting an increase in large islet area fraction. In HC-fed rats, extra-islet insulin(+) clusters (EIC), insulin(+) duct cells, large islet area fraction, and beta-cell mass were increased. Neurogenin-3 and Pdx-1, markers of beta-cell progenitors, were increased in EIC of weanling HC-fed rats. Daily injection of INGAP (30-45 days) increased the number of small islets, total islets, and insulin(+) cells in small ducts. Thus, in BBdp rats fed a protective HC diet, beta-cell expansion is enhanced through increased beta-cell proliferation and stimulation of islet neogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects
  • Aging / pathology*
  • Animals
  • Apoptosis / drug effects
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Caseins / administration & dosage
  • Caseins / pharmacology
  • Cell Aggregation / drug effects
  • Cell Count
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Cell Size / drug effects
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Cytokines / pharmacology
  • Cytoprotection* / drug effects
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / pathology*
  • Diet*
  • Disease Susceptibility / pathology
  • Feeding Behavior*
  • Homeodomain Proteins / metabolism
  • Homeostasis / drug effects
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology*
  • Nerve Tissue Proteins / metabolism
  • Organ Size / drug effects
  • Pancreatitis-Associated Proteins
  • Peptide Fragments / pharmacology
  • Rats
  • Trans-Activators / metabolism

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Caseins
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cytokines
  • Homeodomain Proteins
  • INGAP peptide
  • Nerve Tissue Proteins
  • Neurog3 protein, rat
  • Pancreatitis-Associated Proteins
  • Peptide Fragments
  • REG3A protein, human
  • Trans-Activators
  • pancreatic and duodenal homeobox 1 protein